ELDN (Eledon Pharmaceuticals) Other Current Receivables: $0.58 Mil (As of Mar. 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
27 GF Score
Price $3.94
! 2 Warning Signs
View Full Analysis

What is Eledon Pharmaceuticals Other Current Receivables?

Eledon Pharmaceuticals ELDN -0.76% 27 Other Current Receivables is $0.58 Mil as of Mar. 2026. GuruFocus rates ELDN with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Eledon Pharmaceuticals's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.58 Mil.

Eledon Pharmaceuticals's quarterly Other Current Receivables declined from Sep. 2025 ($0.75 Mil) to Dec. 2025 ($0.51 Mil) but then increased from Dec. 2025 ($0.51 Mil) to Mar. 2026 ($0.58 Mil).

Eledon Pharmaceuticals's annual Other Current Receivables increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.63 Mil) but then declined from Dec. 2024 ($0.63 Mil) to Dec. 2025 ($0.51 Mil).

Eledon Pharmaceuticals Other Current Receivables Related Terms

Eledon Pharmaceuticals Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Other Current Receivables Chart

Eledon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.63 0.51

Eledon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.71 0.75 0.51 0.58
ELDN
27GF Score
Eledon Pharmaceuticals Inc ELDN
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.58 Mil mean?
Eledon Pharmaceuticals (ELDN) has a Other Current Receivables of $0.58 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Other Current Receivables too high?
Eledon Pharmaceuticals' current Other Current Receivables is $0.58 Mil. Overall, Eledon Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Other Current Receivables compare to ZNTL and GLSI?
Eledon Pharmaceuticals' Other Current Receivables of $0.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Other Current Receivables is $0.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Other Current Receivables of $0.58 Mil. The current Other Current Receivables is $0.58 Mil. Eledon Pharmaceuticals' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Other Current Receivables is $0.58 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
27GF Score

Get the complete analysis for ELDN

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.94
Price